Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 4Burkitt Lymphoma 4Multiple Myeloma 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Biphenotypic, Acute 2Ganglioneuroblastoma 2Smoldering Multiple Myeloma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Myeloproliferative Disorders 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Prolymphocytic 1Leukemia, Plasma Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1

Interventions

Specimen Handling 5Biopsy 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 3sodium-iodide symporter 2ruxolitinib 2duvelisib 2cemiplimab 2X-Rays 2Vincristine 2Prednisone 2Photons 2Immunoglobulin G 2Etoposide 2Doxorubicin 2Disulfides 2prednylidene 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Stem Cell Transplantation 1Standard of Care 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Nivolumab 1Melphalan 1Leukapheresis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × Stem Cell Transplantation × 30 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡